SCW.AI forms advisory board to push pharma manufacturing digital transformation

2 hours ago
SCW.AI forms advisory board to push pharma manufacturing digital transformation

SCW.AI has assembled an Industry Advisory Board to guide its push to modernize pharmaceutical manufacturing and prepare customers for AI, compliance and operational demands. The board includes leaders from pharma, CDMO, consulting and supply chain roles as the company expands its Digital Factory platform globally.

Why it matters: - Pharma manufacturers are under pressure to modernize shop-floor operations, strengthen compliance and build the data foundation needed for AI. - SCW.AI is using outside industry guidance to expand its Digital Factory platform and support digital transformation across branded, generic and CDMO segments. - The board signals a push to scale SCW.AI’s impact in regulated manufacturing environments where data-driven execution is becoming more important.

What happened: - SCW.AI announced the formal assembly of its Industry Advisory Board on June 11, 2026. - The company said the board will guide its mission to modernize pharmaceutical manufacturing globally. - SCW.AI said the group will help customers meet evolving demands for AI, advanced technologies, regulatory compliance and operational excellence. - Founder and CEO Evren Ozkaya said SCW.AI focuses first on building the necessary data foundation and data conceptualization layer before AI adoption. - SCW.AI said it is already supporting Pharma 4.0 transformation programs for manufacturers around the world.

The details: - The advisory board members are Brandon Rockwell of PAI Pharma; Ozgur Kilic of restor3d; Robert Ljoljo, formerly of Sandoz Slovenia; Ivan Moller of Zealand Pharma; Sagar Patel, formerly of Pharmanovia; Michael Altman of Kenvue; John Chiminski, formerly of Catalent and now with Bourne Partners; Cevdet Alemdar, formerly of Sabanci Industry and PwC; Cenk Coskunturk of Mediterra Capital; Scott Sims, formerly of Par Health; and Knut Alicke of McKinsey. - SCW.AI described the board as a strategic cross-section of the global manufacturing landscape with deep domain expertise and outside-in innovation. - Ozkaya said the board will help keep SCW.AI’s Digital Factory solutions grounded in real operational challenges. - Ozkaya said the goal is to help customers scale toward a fully data-governed manufacturing environment. - SCW.AI said its platform is compliance-ready and modular. - SCW.AI said the platform is designed for fast time-to-value and rapid deployment. - SCW.AI said the software provides unified visibility and harmonization across assets and sites. - SCW.AI said the platform helps manufacturers move from reactive decision-making to proactive, data-governed operations. - SCW.AI said the platform is powered by Microsoft Azure and uses IoT, manufacturing analytics and AI. - The company said its technology delivers real-time visibility and operational intelligence from shop floors to executive boardrooms. - SCW.AI said the company is a SaaS provider and a global leader in digital factory solutions. - SCW.AI said it is a two-time Inc. 5000 honoree and was recognized by Gartner as a Cool Vendor in Supply Chain Execution Technologies. - SCW.AI said it partners with manufacturers across pharmaceutical and consumer goods industries to build scalable digital solutions. - The source text included a link for more information: the company’s announcement.

Between the lines: - The board mix suggests SCW.AI wants credibility from operators, consultants and former executives who understand regulated manufacturing from multiple angles. - Several quotes frame digital transformation as a competitive necessity rather than a future goal. - The emphasis on data foundations, unified visibility and compliance points to AI as the next layer, not the starting point. - The CDMO and sterile fill/finish references suggest SCW.AI wants to show relevance in complex production environments where execution risk is high.

What’s next: - SCW.AI will likely use the advisory board to shape product direction, market positioning and customer adoption strategy. - The company said the new guidance is intended to help accelerate digital transformation journeys and unlock higher performance, compliance and innovation. - SCW.AI is aiming to expand its impact as manufacturers move toward more automated and AI-enabled operations.

The bottom line: - SCW.AI is betting that a stronger advisory bench will help it sell a broader vision of pharma manufacturing modernization: data first, AI second, and compliance throughout.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Health News Press Slovenia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

Health News Press Slovenia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.